Literature DB >> 9643572

Intravascular lymphomatosis--an indolent or aggressive entity?

V Bogomolski-Yahalom1, I S Lossos, E Okun, Y Sherman, A Lossos, A Polliack.   

Abstract

Intravascular lymphomatosis (IVL) is a rare malignancy characterized by neoplastic proliferation of lymphoid cells within the lumens of arteries, small veins and capillaries. We report four patients with IVL and review the recent world literature, relating to incidence, clinical features and possible therapy. In these cases diagnosis was established coincidentally in one patient after prostatectomy. This patient eventually had central nervous system involvement. In two other patients IVL was diagnosed from skin lesions. In the fourth case the diagnosis was established at post-mortem examination, where involvement of most organs was evident but particularly kidneys, myocardium, gastrointestinal tract and lymph nodes. Therapy was given to three patients, but the disease progressed in two and they both died with evidence of central nervous system involvement, while the third patient has had a good partial response to combination chemotherapy but has relapsed within two months of completing chemotherapy. As evident from our patients and the literature review IVL has a variable clinical course and currently, there appears to be no effective therapy for this rare disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643572     DOI: 10.3109/10428199809050918

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

Review 1.  A new approach to the diagnosis and treatment of intravascular lymphoma.

Authors:  Joachim M Baehring; Janina Longtine; Fred H Hochberg
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

2.  Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan.

Authors:  Atsuko Fujita; Naoto Tomita; Hiroyuki Fujita; Kenji Motohashi; Rie Hyo; Etsuko Yamazaki; Michiko Hattori; Shin Fujisawa; Heiwa Kanamori; Koji Ogawa; Shigeki Motomura; Fumio Kodama; Yoshiaki Ishigatsubo
Journal:  Med Oncol       Date:  2008-06-21       Impact factor: 3.064

3.  Intravascular Large B-Cell Lymphoma: A Difficult Diagnostic Challenge.

Authors:  Maria S Khan; Mark McCubbin; Sucha Nand
Journal:  J Investig Med High Impact Case Rep       Date:  2014-03-06

4.  Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case.

Authors:  Masao Hagihara; Toru Mese; Shin Ohara; Jian Hua; Shiro Ide; Morihiro Inoue
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

5.  Hemophagocytic Syndrome-Associated Variant of Methotrexate-Associated Intravascular Large B-Cell Lymphoma in a Rheumatoid Arthritis Patient.

Authors:  Yukiko Komeno; Minako Akiyama; Yasumi Okochi; Hitoshi Tokuda; Keiko Abe; Kuniko Iihara; Tomiko Ryu
Journal:  Case Rep Hematol       Date:  2019-09-11

6.  The natural history of intravascular lymphomatosis.

Authors:  Ekokobe Fonkem; Edwin Lok; David Robison; Shiva Gautam; Eric T Wong
Journal:  Cancer Med       Date:  2014-06-14       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.